And people wonder why the super rich act the way they do." 3."I work with the uber-rich for a living. In planning an event ...

LG Electronics is thrilled to announce limited-time promotions on LG gram Laptops in collaboration with Marveltm, and exclusively available on LG.com. Continuing to bring value to its customers and ...

Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic ...

In addition to tariffs, the Trump administration is also considering launching a Section 232 investigation into pharmaceuticals, CNBC reported in early April. Such an investigation would determine ...

In this backdrop, shares of pharma companies have taken a hit. Since 2 April close, shares of Biocon and Aurobindo have lost about 10% and 8.6% whereas the stock of Dr Reddy’s is down 4.9%. Sun ...

Even before they've been formally announced, President Trump's 25% pharma import tariffs are succeeding in their goal of bringing more manufacturing to the United States. But that success will ...

In March 2025, among the top-20 pharma companies as per Motilal Oswal Financial Services, JB Chemicals & Pharmaceutical marked a growth of 17.1% YoY, while Cipla Ltd saw sales grow 16.3% YoY.

US drugmakers' shares drop 3% to 6% premarket European, Indian healthcare stocks drag down broader indexes Trump aims to shift pharma manufacturing to US, but analysts doubtful April 9 (Reuters ...

Last Wednesday, when U.S. President Donald Trump unveiled a raft of duties on countries and industries he held back on hitting pharmaceuticals. He followed up on Tuesday by saying he would soon ...

FRANKFURT/LONDON, - European pharma companies warned the European Commission president at a meeting on Tuesday that U.S. tariffs would expedite the industry's shift away from Europe and toward the ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...